My primary research interest is in precision medicine in neuroscience, with a focus on aligning target discovery and biomarker development for preclinical trials.

Target Discovery

I am primarily interested in leveraging biostatistical and machine learning approaches to integrate molecular (single-cell RNA, spatial transcriptomics, proteomics, human genetics) and clinical data to prioritize novel targets and uncover mechanistic insights by generating and testing hypotheses that draw on multi-omic biosignatures, brain biology, genetic evidence, and biobank resources.

Clinical Biomarkers

My research interest in clinical biomarkers focuses on method development for the in-silico identification and analysis of fluid and imaging markers for disease heterogeneity, progression, and treatment response, supporting patient selection, target engagement, and pharmacodynamic evaluation using data from clinical trials and biobanks.